WP2 will develop new varieties/genotypes of crambe and camelina that have an improved oil quality targetting industry demand (e.g. higher levels of mono-unsaturated C18, C20 and C22 fatty acids), higher oil yields and improved valorisation of non-oil and vegetative biomass (e.g. by reducing anti-nutritional factors like glucosinolates and sinapine that currently limit use for insect, cattle, pig and poultry feed). The specific objectives of this WP are:
- To develop site directed mutagenesis with CRISPR/Cas9 for industrial oilseed crops crambe and camelina
- To knockout PUFA production in order to increase mono-unsaturated fatty acid production
- To knockout glucosinolate production in crambe in order to increase the value of the seed meal as feed
- To knockout sinapine production in camelina in order to increase the value of the seed meal as feed
The following partners are involved in WP2:
- Wageningen Research (WP Leader)
Contact: Robert van Loo: E-Mail: [email protected], phone: +31(0)317480879, website - Linnaeus